Zepbound (Tirzepatide) is a prescription medication used to help manage type 2 diabetes by improving blood sugar control. It is a dual GIP and GLP-1 receptor agonist that works by regulating insulin production, reducing glucose production in the liver, and controlling appetite, contributing to weight loss and better glycemic control.
Why Choose Zepbound (Tirzepatide)?
Helps lower blood sugar levels in adults with type 2 diabetes.
Promotes weight loss by reducing hunger and enhancing fat breakdown.
Supports improved glycemic control, reducing the need for insulin.
Convenient once-weekly injection, offering simplicity for users.
May reduce the risk of cardiovascular events in individuals with type 2 diabetes and heart disease.
How to Use Zepbound (Tirzepatide)?
Consult your doctor before starting Zepbound to ensure it’s the right treatment for you.
Follow your doctor’s dosage instructions, typically injected once a week, on the same day each week.
Prepare the injection by cleaning the injection site (usually your stomach, thigh, or upper arm) with an alcohol swab.
Inject the medication subcutaneously as per your doctor’s instructions, rotating the injection sites to avoid irritation.
Monitor your blood sugar regularly as recommended by your healthcare provider.
Important Safety Information for Zepbound
Zepbound is not for people with type 1 diabetes or diabetic ketoacidosis.
May cause a serious condition called gastrointestinal issues, including nausea, vomiting, or diarrhea.
Do not use if allergic to Tirzepatide or any other ingredients in the medication.
Use with caution if you have a history of pancreatitis or other gastrointestinal problems.
Not recommended during pregnancy or breastfeeding unless advised by a healthcare professional.
Fact Table
Facts
Details
Brand Name
Zepbound
Generic Name
Tirzepatide
Medication Type
Dual GIP and GLP-1 Receptor Agonist
Drug Class
Antidiabetic, Weight Loss Medication
Used For
Managing blood sugar in Type 2 Diabetes, Weight loss
Dosage Form
Injectable solution (subcutaneous injection)
Administration
Once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm
Frequency of Use
Once a week, on the same day each week
Mechanism of Action
Dual action on GIP and GLP-1 receptors to improve insulin secretion, lower glucose production, and control appetite
Not for use in pregnancy or breastfeeding unless advised. Regular blood sugar monitoring is recommended
Storage
Store in refrigerator (2°C to 8°C/36°F to 46°F). Do not freeze. Keep out of reach of children.
Prescription Required
Yes
Pregnancy Category
Category C (use only if the benefits outweigh risks, consult a doctor)
Interactions
May interact with other diabetes medications, especially insulin or oral hypoglycemics. Consult a healthcare provider
Common Side Effects
Like all medications, Zepbound (Tirzepatide) can cause side effects, although not everybody gets them. Understanding these side effects can help you use this medication safely and effectively.
Nausea
Diarrhea
Decreased appetite
Vomiting
Constipation
Abdominal pain
If you experience any side effects, discuss them with your healthcare provider. They can offer advice and may adjust your treatment if necessary. Report any severe or unexpected side effects immediately.
